Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L4AL
|
|||
| Former ID |
DNCL001838
|
|||
| Drug Name |
NTx-265
|
|||
| Indication | Stroke [ICD-11: 8B20; ICD-10: I64] | Phase 2 | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00663416) REGENESIS (CA): A Study of NTx 265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.